Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors
Clinical trial NCT01862328 · COMPLETED
Trial details
- NCT number
- NCT01862328
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2018-05-21
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.